Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/114732
Campo DC Valoridioma
dc.contributor.authorNaranjo Hernández, Antonioen_US
dc.contributor.authorPrieto-Alhambra, Danielen_US
dc.contributor.authorSánchez-Martín, Juliánen_US
dc.contributor.authorPérez-Mitru, Alejandroen_US
dc.contributor.authorBrosa, Maxen_US
dc.date.accessioned2022-05-16T14:29:07Z-
dc.date.available2022-05-16T14:29:07Z-
dc.date.issued2022en_US
dc.identifier.issn1178-6981en_US
dc.identifier.otherScopus-
dc.identifier.urihttp://hdl.handle.net/10553/114732-
dc.description.abstractPurpose: To assess the cost-effectiveness of a Fracture Liaison Service (FLS) compared with standard care for the secondary prevention of fragility fractures in Spain. Methods: Patients with osteoporosis and an initial fragility fracture who were candidates to initiate osteoporosis treatment (mean age 65 years, 90.7% female) were included in the model. Disease progression was simulated with a Markov model through seven health states (with and without osteoporosis treatment, subsequent hip, vertebral, forearm and humerus fracture, and death). A time horizon of 10 years and a 6-month duration per cycle was set. Clinical, economic, and quality of life parameters were estimated from the literature and Spanish clinical practice. Resource use and treatment patterns were validated by an expert panel. The Spanish National Health System (SNS) perspective was adopted, taking direct costs (€; 2020) into account. Effectiveness was measured in life-years gained (LYG) and quality-adjusted life years gained (QALYs). A discount rate of 3% was applied to costs and outcomes. The uncertainty of the parameters was assessed using deterministic, scenario and probabilistic sensitivity analyses (1000 iterations). Results: Setting up a FLS for the secondary prevention of fragility fractures in Spain would provide better osteoporosis treatment initiation and persistence. This would reduce subsequent fragility fractures, disutilities and deaths. FLS would have greater clinical benefits (0.008 and 0.082 LYG and QALY gained per patient, respectively) and higher costs (€563.69 per patient) compared with standard care, leading to an incremental cost-utility ratio of €6855.23 per QALY gained over the 10 years horizon. The sensitivity analyses showed limited dispersion of the base case results, corroborating their robustness. Conclusion: From the SNS perspective and considering Spanish willingness-to-pay thresholds, the introduction of FLS for the secondary prevention of fragility fractures would be a cost-effective strategy.en_US
dc.languageengen_US
dc.relation.ispartofClinicoEconomics and Outcomes Researchen_US
dc.sourceClinicoEconomics and Outcomes Research[EISSN 1178-6981],v. 14, p. 249-264, (Abril 2022)en_US
dc.subject32 Ciencias médicasen_US
dc.subject320509 Reumatologíaen_US
dc.subject.otherEconomic Evaluationen_US
dc.subject.otherFracture Liaison Serviceen_US
dc.subject.otherOsteoporotic Fracture Preventionen_US
dc.subject.otherSpainen_US
dc.titleCost-Effectiveness Analysis of Fracture Liaison Services Compared with Standard of Care in the Secondary Prevention of Fragility Fractures in Spainen_US
dc.typeinfo:eu-repo/semantics/Articleen_US
dc.typeArticleen_US
dc.identifier.doi10.2147/CEOR.S350790en_US
dc.identifier.scopus85129441169-
dc.contributor.orcidNO DATA-
dc.contributor.orcidNO DATA-
dc.contributor.orcidNO DATA-
dc.contributor.orcidNO DATA-
dc.contributor.orcidNO DATA-
dc.contributor.authorscopusid57666409200-
dc.contributor.authorscopusid35788288300-
dc.contributor.authorscopusid57666736500-
dc.contributor.authorscopusid57192990390-
dc.contributor.authorscopusid6505813183-
dc.identifier.eissn1178-6981-
dc.description.lastpage264en_US
dc.description.firstpage249en_US
dc.relation.volume14en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.description.numberofpages16en_US
dc.utils.revisionen_US
dc.date.coverdateAbril 2022en_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.sjr0,5
dc.description.sjrqQ2
dc.description.esciESCI
dc.description.miaricds9,6
item.grantfulltextnone-
item.fulltextSin texto completo-
crisitem.author.deptGIR IUIBS: Grupo de investigaciones infecciosas, nutricionales e inflamatorias en pacientes hospitalarios / Study Group on infectious, nutritional and inflammatory diseases in hospitalized patients-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Ciencias Médicas y Quirúrgicas-
crisitem.author.orcid0000-0002-2013-6664-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameNaranjo Hernández, Antonio-
Colección:Artículos
Vista resumida

Citas SCOPUSTM   

9
actualizado el 17-nov-2024

Citas de WEB OF SCIENCETM
Citations

8
actualizado el 17-nov-2024

Visitas

52
actualizado el 30-mar-2024

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.